Skip to content

Myopic Control for High Myopes Using Orthokeratology

High Myopia - Partial Reduction Orthokeratology Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00977236
Acronym
HM-PRO
Enrollment
52
Registered
2009-09-15
Start date
2008-07-31
Completion date
2012-12-31
Last updated
2013-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

children, corneal reshaping, myopia, myopia control, orthokeratology

Brief summary

The purpose of this study is to evaluate and compare the eyeball elongation in high myopic children using partial correction orthokeratology and single-vision spectacles.

Detailed description

Orthokeratology (ortho-k) has been shown to have strong potential for retardation of myopic progression in low myopes. To date, clinical experience has shown the technique to be less effective in achieving full myopic reduction in high myopes. Would myopic control be possible for high myopes undergoing partial correction ortho-k treatment? A randomized, longitudinal study is designed to investigate the efficacy of partial correction ortho-k in retardation of myopic progression in high myopic children. Eye growth in terms of axial length elongation in children wearing ortho-k and over-spectacles (to correct residual refractive errors) (study group) and those wearing single-vision spectacles (control group) will be evaluated and compared.

Interventions

Nightly use of orthokeratology to correct the refractive error and over-specs for a period of two years

Daily use of spectacles to correct the refractive error for a period of two years

Sponsors

Procornea Nederland B.V.
CollaboratorUNKNOWN
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
8 Years to 11 Years
Healthy volunteers
Yes

Inclusion criteria

* Myopia (refractive sphere): \> 5.75D * Astigmatism: \< ½ of myopia; with-the-rule astigmatism (axes 180 +/- 30) ≤1.25D; astigmatism of other axes ≤ 0.50D * Spherical equivalent (SE): \> 5.75D * Anisometropia: ≤ 1.50D in both refractive sphere, refractive cylinder and SE * Best corrected monocular visual acuity: equal to or better than 0.10 in logMAR scale in both eyes * Willingness for randomization * Availability for follow-up for at least 2 years

Exclusion criteria

* Strabismus at distance or near * Contraindication for contact lens wear and orthokeratology (e.g. limbus to limbus corneal cylinder and dislocated corneal apex * Systemic or ocular conditions which may affect contact lens wear (e.g. allergy and medication) * Systemic or ocular conditions which may affect refractive development (e.g. Down syndrome, ptosis)

Design outcomes

Primary

MeasureTime frame
Determine the change in cycloplegic axial length in the study and control groups2 years

Secondary

MeasureTime frame
Determine the incidence of adverse effects in cornea, the palpebral, bulbar and tarsal conjunctiva in the study and the control groups2 years
Rate of regression during the daytime2 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026